Capital Fund Management S.A. Mirati Therapeutics, Inc. Transaction History

Capital Fund Management S.A.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$41.27 - $98.62 $416,579 - $995,470	-10,094 Reduced 19.36%	42,056 $1.91 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $508,189 - $740,504	8,541 Added 19.59%	52,150 $3.64 Billion
Q2 2022 Aug 12, 2022	SELL	$39.16 - $88.71 $262,606 - $594,889	-6,706 Reduced 13.33%	43,609 $2.93 Million
Q1 2022 May 12, 2022	BUY	$75.82 - $150.97 $1.91 Million - $3.81 Million	25,253 Added 100.76%	50,315 $4.14 Million
Q4 2021 Feb 10, 2022	BUY	$132.01 - $190.29 $1.18 Million - $1.7 Million	8,932 Added 55.38%	25,062 $3.68 Million
Q3 2021 Nov 12, 2021	BUY	$132.13 - $177.45 $244,704 - $328,637	1,852 Added 12.97%	16,130 $2.85 Million
Q2 2021 Aug 12, 2021	BUY	$144.0 - $179.73 $2.06 Million - $2.57 Million	14,278 New	14,278 $2.31 Million
Q3 2020 Nov 13, 2020	SELL	$113.26 - $167.27 $1.61 Million - $2.38 Million	-14,241 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$72.01 - $120.39 $30,316 - $50,684	421 Added 3.05%	14,241 $1.63 Million
Q1 2020 May 13, 2020	SELL	$69.78 - $116.21 $566,613 - $943,625	-8,120 Reduced 37.01%	13,820 $1.06 Million
Q4 2019 Feb 13, 2020	BUY	$70.76 - $128.86 $960,779 - $1.75 Million	13,578 Added 162.38%	21,940 $2.83 Million
Q3 2019 Nov 13, 2019	BUY	$77.91 - $109.6 $651,483 - $916,475	8,362 New	8,362 $651,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.